0
0.5
1
1.5
2+
Improvement
-40%
Improvement
Relative Risk
Improvement (b)
-36%
Improvement (c)
-64%
Favipiravir Adhikari et al. EARLY TREATMENT RCT
Is early treatment with favipiravir beneficial for COVID-19?
RCT 70 patients in Nepal (May - October 2020)
Worse improvement with favipiravir (not stat. sig., p=0.57)
c19early.org
Adhikari et al., Int. J. Infectious Di.., Mar 2022
Favors favipiravir
Favors control